000			01925 a2200529 4500
005			20250516013426.0
264		0	_c20110222
008			201102s 0 0 eng d
022			_a1533-712X
024	7		_a10.1097/jcp.0b013e3181fae248 _2doi
040			_aNLM _beng _cNLM
100	1		_aPerez-Iglesias, Rocio
245	0	0	_aEffect of FTO, SH2B1, LEP, and LEPR polymorphisms on weight gain associated with antipsychotic treatment. _h[electronic resource]
260			_bJournal of clinical psychopharmacology _cDec 2010
300			_a661-6 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdaptor Proteins, Signal Transducing _xgenetics
650	0	4	_aAdult
650	0	4	_aAlpha-Ketoglutarate-Dependent Dioxygenase FTO
650	0	4	_aAntipsychotic Agents _xadverse effects
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGenetic Predisposition to Disease
650	0	4	_aGenotype
650	0	4	_aHumans
650	0	4	_aLeptin _xgenetics
650	0	4	_aLongitudinal Studies
650	0	4	_aMale
650	0	4	_aPolymorphism, Single Nucleotide
650	0	4	_aProspective Studies
650	0	4	_aProteins _xgenetics
650	0	4	_aPsychotic Disorders _xdrug therapy
650	0	4	_aReceptors, Leptin _xgenetics
650	0	4	_aSchizophrenia _xdrug therapy
650	0	4	_aWeight Gain _xdrug effects
650	0	4	_aYoung Adult
700	1		_aMata, Ignacio
700	1		_aAmado, Jose Antonio
700	1		_aBerja, Ana
700	1		_aGarcia-Unzueta, Maria Teresa
700	1		_aMartínez García, Obdulia
700	1		_aArranz, Maria Jesús
700	1		_aVazquez-Barquero, Jose Luis
700	1		_aCrespo-Facorro, Benedicto
773	0		_tJournal of clinical psychopharmacology _gvol. 30 _gno. 6 _gp. 661-6
856	4	0	_uhttps://doi.org/10.1097/jcp.0b013e3181fae248 _zAvailable from publisher's website
999			_c20398464 _d20398464